Pathologically, Alzheimer's disease (AD) is characterized by the presence of (Aβ)-containing extracellular deposits and intracellular aggregations of hyperphosphorylated tau in the brains of affected patients (Deture and Dickson, 2019; Long and Holtzman, 2019). Here, MAPT is linked to Alzheimer disease.